A comparative study to evaluate salivary biomarker interleukin-6 in oral squamous cell carcinoma and oral potentially malignant disorders. CDF [Internet]. 2025 Jan. 10 [cited 2026 Apr. 22];54(2):864-8. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/804